Dr Michael Andrew Howell, MD | |
2100 Manatee Ave W, Bradenton, FL 34205-5428 | |
(941) 896-8676 | |
(941) 896-8681 |
Full Name | Dr Michael Andrew Howell |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 18 Years |
Location | 2100 Manatee Ave W, Bradenton, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053580191 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | ME106444 (Florida) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sunshine Medicine Pa | 9133537301 | 3 |
News Archive
Merck today announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S. Food and Drug Administration (FDA). The Company is also moving forward as planned with regulatory filings in countries outside the United States.
The Sohn Conference Foundation today announced a $50,000 grant to support funding of a Phase 2 cutting-edge pediatric clinical trial from the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) now extending to New York City.
Health authorities in Paraguay have confirmed 5 cases of yellow fever in the Department of San Pedro.
The age-old debate of 'nature versus nurture', of how much our personality and behaviours are shaped by biology or our environment, is sharpening up as scientists' exploration of the human brain gets ever more sophisticated.
Bone Biologics Inc. has announced that it has received a US Patent Office Notice of Allowance of patent claims which protect a method of production for the UCB-1 (NELL-1) recombinant protein that Bone Biologics uses in the bone repair/regeneration technology in its lead product.
› Verified 5 days ago
Entity Name | Sunshine Medicine Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205439346 PECOS PAC ID: 9133537301 Enrollment ID: O20210428001248 |
News Archive
Merck today announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S. Food and Drug Administration (FDA). The Company is also moving forward as planned with regulatory filings in countries outside the United States.
The Sohn Conference Foundation today announced a $50,000 grant to support funding of a Phase 2 cutting-edge pediatric clinical trial from the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) now extending to New York City.
Health authorities in Paraguay have confirmed 5 cases of yellow fever in the Department of San Pedro.
The age-old debate of 'nature versus nurture', of how much our personality and behaviours are shaped by biology or our environment, is sharpening up as scientists' exploration of the human brain gets ever more sophisticated.
Bone Biologics Inc. has announced that it has received a US Patent Office Notice of Allowance of patent claims which protect a method of production for the UCB-1 (NELL-1) recombinant protein that Bone Biologics uses in the bone repair/regeneration technology in its lead product.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael Andrew Howell, MD 2100 Manatee Ave W, Bradenton, FL 34205-5428 Ph: (941) 896-8676 | Dr Michael Andrew Howell, MD 2100 Manatee Ave W, Bradenton, FL 34205-5428 Ph: (941) 896-8676 |
News Archive
Merck today announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S. Food and Drug Administration (FDA). The Company is also moving forward as planned with regulatory filings in countries outside the United States.
The Sohn Conference Foundation today announced a $50,000 grant to support funding of a Phase 2 cutting-edge pediatric clinical trial from the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) now extending to New York City.
Health authorities in Paraguay have confirmed 5 cases of yellow fever in the Department of San Pedro.
The age-old debate of 'nature versus nurture', of how much our personality and behaviours are shaped by biology or our environment, is sharpening up as scientists' exploration of the human brain gets ever more sophisticated.
Bone Biologics Inc. has announced that it has received a US Patent Office Notice of Allowance of patent claims which protect a method of production for the UCB-1 (NELL-1) recombinant protein that Bone Biologics uses in the bone repair/regeneration technology in its lead product.
› Verified 5 days ago
Anthony J Montanaro, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1533 4th Ave W, Bradenton, FL 34205 Phone: 941-527-0259 Fax: 941-527-0263 | |
Svetlana Kovtunova, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 206 2nd St E, Bradenton, FL 34208 Phone: 941-746-5111 Fax: 941-845-4963 | |
Dr. Robert E Blackwood, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7005 Cortez Rd W, Bradenton, FL 34210 Phone: 941-792-2122 Fax: 941-798-2019 | |
Marcella P Jones, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 5534 Cortez Rd W, Bradenton, FL 34210 Phone: 941-757-2100 Fax: 941-757-2101 | |
Kelly Duggin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8340 Lakewood Ranch Blvd, Suite 210, Bradenton, FL 34202 Phone: 941-782-2800 Fax: 941-782-2513 | |
Dr. Deepa Manik Makhijani, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3649 Cortez Rd W, Bradenton, FL 34210 Phone: 941-753-7585 |